Matthew Powell, MD

Conference Coverage

Addition of Pembrolizumab and Olaparib Improves Survival for Patients With Advanced Non–BRCA-Mutated Epithelial Ovarian Cancer

03/20/2025

Matthew Powell , MD;

Matthew Powell, MD, discusses results from the KEYLINK-001 study which demonstrated that the addition of pembrolizumab and olaparib to standard therapy improved progression-free survival among patients with advanced BRCA non-mutated...

Matthew Powell, MD, discusses...

03/20/2025

Oncology

Featured CME

The Medication Access and Training Expansion (MATE) Act requires prescribers renewing their DEA registration to have completed at least 8 hours of training on opioid or other substance use disorders.

Upcoming Events

April 5 ⁠–⁠ April 6

April 21 ⁠–⁠ April 24

April 29 ⁠–⁠ April 30

April 30 ⁠–⁠ May 4

May 1 ⁠–⁠ May 2

May 7 ⁠–⁠ May 9

May 8 ⁠–⁠ May 10

May 14 ⁠–⁠ May 16

May 19 ⁠–⁠ May 21

May 28 ⁠–⁠ May 31

See Full Calendar

Matthew Powell, MD

Featured CME

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products